Newsroom

Featured

Lotus Pharmaceuticals Obtained European Approval of Gefitinib, A Generic Iressa®, For Multiple European Countries as First Wave Generics

Lotus Pharmaceuticals Obtained European Approval of Gefitinib, A Generic Iressa®, For Multiple European Countries as First Wave Generics

Read More
1 2 3 4 ... 6
MEET THE MANAGEMENT

Highly experienced management team with a proven track record of achieving high growth and profitability.

 

News alert

Enter your email to sign up for news alerts